Ermital, capsules 25000 units 50 pcs

Ermital contains standard highly active pancreatin derived from the pancreas of pigs in the form of micro tablets resistant to gastric juice.

The digestive enzyme, replenishes pancreatic enzyme deficiencies, has proteolytic, amylolytic and lipolytic action.

Included enzymes (lipase, alpha-amylase, trypsin, chymotrypsin) help to breakdown proteins into amino acids, fats into glycerol and fatty acids, starch into dextrins and monosaccharides, improves the functional state of the gastrointestinal tract and normalizes digestive processes.

Pharmacodynamics

The form of the drug ensures complete release of the gastric juice-resistant microtablets from the capsule in the stomach, followed by fine mixing of the microtablets with

intestinal contents and chyme and rapid release of enzymes from the microtablets in the duodenum at pH>5.

Pancreatic enzyme breakdown products are absorbed in the intestine either directly or after breakdown by intestinal enzymes.

Pharmacokinetics

The pancreatic enzymes contained in Hermital are not absorbed into the blood. The enzymes are inactivated and digested in the intestine as proteins by autolysis and proteolysis.

The residual enzymatic activity can be determined in the stool.

Indications

Active ingredient

How to take, the dosage

Interaction

The absorption of folic acid may be decreased when taking Ermital® .

The effect of the oral hypoglycemic drugs acarbose and miglitol may be decreased during treatment with Ermital® .

Special Instructions

Contraindications

Side effects

Overdose

Symptoms: hyperuricosuria, hyperuricemia.

Treatment: drug withdrawal, symptomatic therapy.

Pregnancy use

The use of the drug during lactation (breastfeeding) is possible only when the estimated benefit of therapy for the mother outweighs the potential risk to the infant.

It is contraindicated in children.

Similarities